Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2010 - 2023)
Tenax Therapeutics (TENX) reported Depreciation & Amortization (CF) of $5136.0 for Q4 2023, up 281.86% on a YoY basis from $1345.0 in Q4 2022, and up 430.03% sequentially from $969.0 in Q3 2023.
Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends
Tenax Therapeutics (TENX) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $5136.0 in Q4 2023.
- For the quarter ending Q4 2023, Depreciation & Amortization (CF) rose 281.86% year-over-year to $5136.0; the trailing twelve-month figure through Sep 2024 stood at $5136.0 (up 22.02% YoY), and the FY2023 full-year result was $8000.0, up 55.55% from the prior year.
- Depreciation & Amortization (CF) grew to $5136.0 in Q4 2023, from $969.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $5136.0 in Q4 2023 to a low of $891.0 in Q2 2021.
- A 5-year average of $1317.6 and a median of $1113.5 in 2019 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 56.74% in 2019 and soared 281.86% in 2023, its largest moves.
- Tracing TENX's Depreciation & Amortization (CF) over 5 years: stood at $1308.0 in 2019, then fell by 25.15% to $979.0 in 2020, then gained by 10.21% to $1079.0 in 2021, then gained by 24.65% to $1345.0 in 2022, then soared by 281.86% to $5136.0 in 2023.
- Business Quant data shows TENX's Depreciation & Amortization (CF) at $5136.0 in Q4 2023, $969.0 in Q3 2023, and $1000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5,136.00 |
| Dec 31, 2023 | 5,136.00 |
| Sep 30, 2023 | 969.00 |
| Sep 30, 2023 | 969.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 895.00 |
| Mar 31, 2023 | 895.00 |
| Dec 31, 2022 | 1,345.00 |
| Dec 31, 2022 | 1,345.00 |
| Sep 30, 2022 | 1,210.00 |
| Sep 30, 2022 | 1,210.00 |
| Jun 30, 2022 | 1,235.00 |
| Jun 30, 2022 | 1,235.00 |
| Mar 31, 2022 | 1,353.00 |
| Mar 31, 2022 | 1,353.00 |
| Dec 31, 2021 | 1,079.00 |
| Dec 31, 2021 | 1,079.00 |
| Sep 30, 2021 | 1,011.00 |
| Sep 30, 2021 | 1,011.00 |